Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 12(8): e0182480, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28796788

RESUMEN

The protozoan Entamoeba histolytica is the etiological agent of amoebiasis, which can spread to the liver and form amoebic liver abscesses. Histological studies conducted with resistant and susceptible models of amoebic liver abscesses (ALAs) have established that neutrophils are the first cells to contact invasive amoebae at the lesion site. Myeloperoxidase is the most abundant enzyme secreted by neutrophils. It uses hydrogen peroxide secreted by the same cells to oxidize chloride ions and produce hypochlorous acid, which is the most efficient microbicidal system of neutrophils. In a previous report, our group demonstrated that myeloperoxidase presents amoebicidal activity in vitro. The aim of the current contribution was to analyze in vivo the role of myeloperoxidase in a susceptible (hamsters) and resistant (Balb/c mice) animal models of ALAs. In liver samples of hamsters and mice inoculated intraportally with Entamoeba histolytica trophozoites, the number of neutrophils in ALAs was determined by enzymatic activity. The presence of myeloperoxidase was observed by staining, and its expression and activity were quantified in situ. A significant difference existed between the two animal models in the number of neutrophils and the expression and activity of myeloperoxidase, which may explain the distinct evolution of amoebic liver abscesses. Hamsters and mice were treated with an MPO inhibitor (4-aminobenzoic acid hydrazide). Hamsters treated with ABAH showed no significant differences in the percentage of lesions or in the percentage of amoebae damaged compared with the untreated hamsters. ABAH treated mice versus untreated mice showed larger abscesses and a decreased percentage of damaged amoebae in these lesion at all stages of evolution. Further studies are needed to elucidate the host and amoebic mechanisms involved in the adequate or inadequate activation and modulation of myeloperoxidase.


Asunto(s)
Entamoeba histolytica/fisiología , Absceso Hepático Amebiano/enzimología , Peroxidasa/metabolismo , Animales , Cricetinae , Modelos Animales de Enfermedad , Resistencia a la Enfermedad , Interacciones Huésped-Patógeno , Elastasa de Leucocito/metabolismo , Hígado/enzimología , Hígado/inmunología , Hígado/parasitología , Masculino , Ratones Endogámicos BALB C , Neutrófilos/enzimología
2.
Parasite ; 23: 6, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26880421

RESUMEN

Host invasion by Entamoeba histolytica, the pathogenic agent of amebiasis, can lead to the development of amebic liver abscess (ALA). Due to the difficulty of exploring host and amebic factors involved in the pathogenesis of ALA in humans, most studies have been conducted with animal models (e.g., mice, gerbils, and hamsters). Histopathological findings reveal that the chronic phase of ALA in humans corresponds to lytic or liquefactive necrosis, whereas in rodent models there is granulomatous inflammation. However, the use of animal models has provided important information on molecules and mechanisms of the host/parasite interaction. Hence, the present review discusses the possible role of neutrophils in the effector immune response in ALA in rodents. Properly activated neutrophils are probably successful in eliminating amebas through oxidative and non-oxidative mechanisms, including neutrophil degranulation, the generation of free radicals (O2(-), H2O2, HOCl) and peroxynitrite, the activation of NADPH-oxidase and myeloperoxidase (MPO) enzymes, and the formation of neutrophil extracellular traps (NETs). On the other hand, if amebas are not eliminated in the early stages of infection, they trigger a prolonged and exaggerated inflammatory response that apparently causes ALAs. Genetic differences in animals and humans are likely to be key to a successful host immune response.


Asunto(s)
Absceso Hepático Amebiano/inmunología , Neutrófilos/inmunología , Animales , Apoptosis , Degranulación de la Célula , Hipoxia de la Célula , Cricetinae , Susceptibilidad a Enfermedades , Entamoeba histolytica/genética , Entamoeba histolytica/fisiología , Trampas Extracelulares , Femenino , Gerbillinae , Inflamación , Absceso Hepático Amebiano/patología , Masculino , Ratones , Ratones SCID , Modelos Animales , NADPH Oxidasas/fisiología , Peroxidasa/fisiología , Ratas , Estallido Respiratorio , Especificidad de la Especie
3.
Biomed Res Int ; 2014: 324230, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24822193

RESUMEN

The molecular mechanisms by which Entamoeba histolytica causes amebic liver abscess (ALA) are still not fully understood. Amebic mechanisms of adherence and cytotoxic activity are pivotal for amebic survival but apparently do not directly cause liver abscess. Abundant evidence indicates that chronic inflammation (resulting from an inadequate immune response) is probably the main cause of ALA. Reports referring to inflammatory mechanisms of liver damage mention a repertoire of toxic molecules by the immune response (especially nitric oxide and reactive oxygen intermediates) and cytotoxic substances released by neutrophils and macrophages after being lysed by amoebas (e.g., defensins, complement, and proteases). Nevertheless, recent evidence downplays these mechanisms in abscess formation and emphasizes the importance of peroxynitrite (ONOO(-)). It seems that the defense mechanism of amoebas against ONOO(-), namely, the amebic thioredoxin system (including peroxiredoxin), is superior to that of mammals. The aim of the present text is to define the importance of ONOO(-) as the main agent of liver abscess formation during amebic invasion, and to explain the superior capacity of amoebas to defend themselves against this toxic agent through the peroxiredoxin and thioredoxin system.


Asunto(s)
Interacciones Huésped-Parásitos , Absceso Hepático Amebiano , Modelos Biológicos , Peroxirredoxinas , Ácido Peroxinitroso , Animales , Línea Celular , Cricetinae , Humanos , Inflamación , Ratones , Ratas
4.
Can J Microbiol ; 56(12): 987-95, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21164568

RESUMEN

Trophozoites of Entamoeba histolytica HM-1:IMSS become less virulent after long-term maintenance in axenic cultures. The factors responsible for the loss of virulence during in vitro cultivation remain unclear. However, it is known that in vitro cultivation of amoeba in culture medium supplemented with cholesterol restores their virulence. In this study, we analyzed the effect of adding phosphatidylcholine-cholesterol (PC-Chol) liposomes to the culture medium and evaluated the effect of this lipid on various biochemical and biological functions of E. histolytica HM-1:IMSS in terms of its virulence. The addition of PC-Chol liposomes to the culture medium maintained the virulence of these parasites against hamster liver at the same level as the original virulent E. histolytica strain, even though these amoebae were maintained without passage through hamster liver for 18 months. The trophozoites also showed increased endocytosis, erythrophagocytosis, and carbohydrate residue expression on the amoebic surface. Protease activities were also modified by the presence of cholesterol in the culture medium. These findings indicate the capacity of cholesterol to preserve amoeba virulence and provide an alternative method for the maintenance of virulent E. histolytica trophozoites without the need for in vivo procedures.


Asunto(s)
Colesterol/farmacología , Entamoeba histolytica/efectos de los fármacos , Entamoeba histolytica/patogenicidad , Absceso Hepático Amebiano/parasitología , Fosfatidilcolinas/farmacología , Animales , Colesterol/análisis , Concanavalina A/análisis , Cricetinae , Medios de Cultivo/química , Endocitosis/efectos de los fármacos , Entamoeba histolytica/enzimología , Entamoeba histolytica/crecimiento & desarrollo , Eritrocitos/efectos de los fármacos , Liposomas/farmacología , Masculino , Péptido Hidrolasas/metabolismo , Fagocitosis/efectos de los fármacos , Trofozoítos/efectos de los fármacos , Trofozoítos/enzimología , Trofozoítos/crecimiento & desarrollo , Virulencia/efectos de los fármacos , Factores de Virulencia/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...